MD F A F C A C MAS A N S C

Similar documents
FFR-CT Not Ready for Primetime

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Current and Future Imaging Trends in Risk Stratification for CAD

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

Chest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test

Hybrid Imaging Improving Nuclear Cardiology Practice

Stress only Perfusion Imaging

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Stress Testing:Which Study is Indicated for My Patient?

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Welcome! To submit questions during the presentation: or Text:

Test in Subjects with Suspected CAD Anatomic Study is Better

I have no financial disclosures

Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations

Calcium scoring Clinical and prognostic value

PET myocard perfusion & viability Riemer Slart

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Εξελίξεις και νέες προοπτικές στην καρδιαγγειακή απεικόνιση CT. Σταμάτης Κυρζόπουλος Ωνάσειο Καρδιοχειρουργικό Κέντρο

Evaluating Clinical Risk and Guiding management with SPECT Imaging

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

CT or PET/CT for coronary artery disease

Overview. Health and economic burden of coronary artery disease (CAD) Pitfalls in care of patients suspected of having CAD

Diagnostic and Prognostic Value of Coronary Ca Score

SPECT CT Current Status and Future Direction Nuclear Cardiology

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Testing the Asymptomatic CAD Patient: When and Why?

Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Evidence for Everyone: Expanding the Reach of Health Technology Assessment 2016 CADTH Symposium, April 10-12, Shaw Centre, Ottawa

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018

MINIMIZING RADIATION EXPOSURE

Conflict of Interest Disclosure

New Insight about FFR and IVUS MLA

Conflict of Interest Disclosure

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

Advanced Imaging MRI and CTA

Chest pain. One problem different approaches... Question 1 what is your choice? In-/Exclusion Criteria

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Physiologic Assessment by Cardiac CT

Risk Stratification for CAD for the Primary Care Provider

Atypical pain and normal exercise test

How to investigate (Cardiac) Chest Pain

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

Imaging of the Heart Todd Tessendorf MD FACC

Reducing the Population Health Burden of Cardiovascular Disease

Coronary interventions

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Machine learning improves image analysis prognosis and diagnosis in cardiac imaging

Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment

Diagnosis of CAD S Richard Underwood

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

The role of Cardiac CT

New Paradigms in Predicting CVD Risk

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

Recent Advances in Nuclear Cardiology, Cardiac CT, and Cardiac MRI: Applications for CAD in the Era of Value-based Imaging

State-of-the-Art SPECT/CT: Cardiac Imaging

Role of Myocardial Perfusion Imaging in the Cardiac Evaluation of Aviators

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

DIAGNOSTIC TESTING IN PATIENTS WITH STABLE CHEST PAIN

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Typical chest pain with normal ECG

Is computed tomography angiography really useful in. of coronary artery disease?

Chest Pain Wave I. Making Dollars and Sense Out of Stress Testing

MEDICAL UNIVERSITY of SOUTH CAROLINA

CT Myocardial Perfusion: Is there Added Value to Coronary CT?

Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: State-of-the-Art Updates and 101 Evidence-Based Case Reviews

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

Non Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal

The Role of Nuclear Imaging in Heart Failure

Cardiac CT Angiography

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

Diabetes and Occult Coronary Artery Disease

New Challenges in Nuclear Cardiology Practice

Preview of Presentation

Guideline Number: NIA_CG_024 Last Review Date: January 2011 Responsible Department: Last Revised Date: May 2, 2011 Clinical Operations

Disclosure Information

Is Myocardial Perfusion Imaging an Important Predictor of Mortality in Women

CHRONIC CAD DIAGNOSIS

Advantages of PET Myocardial Imaging

The use of Cardiac CT and MRI in Clinical Practice

Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah. March 2017

What the Cardiologist needs to know from Medical Images

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

CLINICAL PRACTICE GUIDELINES AND APPROPRIATE USE CRITERIA

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

2016 Qualified Clinical Data Registry (QCDR) Performance Measures

Journal of the American College of Cardiology Vol. 50, No. 11, by the American College of Cardiology Foundation ISSN /07/$32.

Microvascular Disease: How to Diagnose and What s its Treatment

CT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

Transcription:

Myocardial Perfusion Imaging and Coronary Calcium Scoring: Complimentary or Competitive David Wolinsky MD FACC MASNC Section Head Nuclear Cardiology, Cleveland Clinic Florida Immediate Past President, American Society Nuclear Cardiology Disclosures Speaker Astellas Pharma Consultant Astellas Pharma Steering Committee Adenosine Therapeutics Immediate Past President ASNC Discussion Anatomy vs Physiology Long term vs Short Term Risk Assessment Value of MPI The patient with very high Calcium ScoreAssessment Positive Family History Assessing Incidental Coronary Calcium PET Perfusion 1

Cardiac Testing What ;Why? The Value of Noninvasive Testing Traditional Determine cause of symptoms Diagnose disease Define treatment Risk Stratify Modern Paradigm Shaw JACC Imaging 2010 No One Pair of Shoes for ALL Occasions 2

Anatomic vs Functional Imaging Courtesy Leslee Shaw PhD Calcium Score vs MPI Calcium Score MPI Anatomic Test Defines atherosclerosis Long term risk associated with increasing CAC score Used in assessing Asymptomatic patients Combined with CCTA, PET,SPECT for symptomatic patients Guideline to medical therapy or further noninvasive testing Physiologic test Short term risk (2 yr) very low with negative test Risk stratifies symptomatic patients Gatekeeper to invasive studies Proven management chronic CAD Diagnostic Accuracy MPI Shaw Jl Nuc Card 2012 3

Prognostic Value Normal MPI Shaw Jl Nuc Card 2012 Stress MPI and Risk Hachamovitch Jl Nuc Card 2005 Shaw Jl Nuc Card 2012 SPECT vs PET SPECT Readily available Extensive AUC Extensive Outcomes data based on stress results Data on Medical vs Revascularization therapy Exercise stress data Raw Spinning Data PET Less available, $$$$$ No specific AUC Limited outcomes data Only pharm stress Attenuation Correction Lower radiation Less training Coronary flow reserve Less likely to be covered by insurance 4

What is Interelationship Between MPI and Calcium Score Prognosis MPI Shaw JNC 2012 Multimodality AUC http://dx.doi.org/10.1016/j.jacc.2013.11.009 5

Sequential Testing http://dx.doi.org/10.1016/j.jacc.2013.11.009 Relationship CAC and Ischemia Predominantly symptomatic pts Intermediate pretest risk Schenker et al Circulation. 2008;117:1693-1700.) 6

Ability CAC to Predict Ischemia Risk Stratification- Hard Events Absolute Stratification by MPI Relative Stratification by CAC Schenker et al Conclusion PET can achieve effective risk stratification for major cardiac events with good discrimination between high and low risk patients in patients with intermediate pretest risk Two year risk stratification with MPI provides an appropriate warranty period for a normal scan and appropriate risk that justifies further therapy in abnormal scans (Await ISCHEMIA) CAC can define long term risk. It can help determine which is the most appropriate functional test to do. It may also help refine risk of subsequent testing 7

The Patient with Very High Calcium Score- Greater than 1000 Concern that with severe extensive coronary disease that stress testing would provoke balanced ischemia and false negative stress test Triple vessel disease vs left main CAD Ancillary markers ECG, TID may help LVG 47 yo male HTN, FHX, Active tobacco (30-40 pack- years), Poor diet, History carotid stenosis. On Pravachol Calcium Score 2057 SOB climbing 15 stairs. No chest Pain Normal ECG LVG Intermediate to high risk Referred for MPI 11.9 METS No chest pain. No ECG changes Normal Perfusion Rest stress study No TID Normal EF 8

LVG LVG What is His Risk? Pilot Study Nonconclusive Unusual Finding Relatively uncommon finding Yuoness Eur J Nucl Med Mol Imaging (2015) 42:1542 1550 9

Does presence of Significant CAC modify risk of normal MPI CAC increases pretest likelihood of having ischemia (Baye s Theorem) Is their a difference in prognosis between patients followed with CAC and normal MPI and patients followed with normal MPI? Rozanski JACC Vol. 49, No. 12, 2007 :1352 61 CAC did not modify MPI based risk Patients with CAC did not have increased risk with normal scan Presence of CAC did not change risk based on clinical and MPS alone Evaluation of the Patient with Postive Family History Doc. I want all the tests done. My best friend just died. My father had a heart attack at 58. I want everything. I have great insurance. They will cover everything. Do it all! 10

Family History CAD Framingham does not include +FHx FHx cannot be quantitated There is no data supporting advanced imaging stress testing in this population. Can CAC be a surrogate for +FHX and help determine high risk patients? Does CAC modify risk stratification of MPI in these patient? Family History CAD There is an asssociation between premature CAD and presence of CAC. CAC provides long term risk stratification. There is no data to suggest CAC modifies short short term mortality risk in these patients beyond the general population Many of these patient have too low a risk profile at time they are studied Nasir Circ 2007. Knapper and Shaw Heart 2016 PET Do it Right Bad PET is not a substitute for Bad SPECT PET is not a substitute for SPECT if the patient can exercise and has good imaging characteristics PET s true value is not improved images but coronary flow reserve (CFR) Doing CFR is not easy 11

PET Perfusion-Rb Courtesy Wael Jaber MD Abnormal PET Perfusion Courtesy Wael Jaber MD PET-CT Attenuation Correction 12

Coronary Flow Reserve 13

Reclassification with CFR Courtesy Leslee Shaw PhD 14

Summary SPECT and PET MPI are valuable tools for assessing coronary physiology and determining ischemic burden. They are most appropriately used in assessing intermediate to high risk symptomatic patients. CAC assesses the presence of preclinical atherosclerosis and long term risk Though often used in different populations, when combined in appropriate patients they are complementary to fine tune short term risk I have a simple view of Calcium Score- We Need Dr Nasir Segmental rest perfusion measurements ranged from 0.8 to 0.9 ml/min/g of tissue, while hyperemic measurements ranged from 3.1 to 3.3 ml/min/g of tissue. Myocardial perfusion reserve measurements ranged from 3.3 to 3.6. Thank you 15

16